About Mycardium AI
MyCardium AI is a medical technology company that combines innovation and expertise to revolutionize cardiac imaging through artificial intelligence. The company develops FDA 510(k) cleared and CE Class IIB certified AI software solutions for cardiac diagnostics, including 1CMR Pro for cardiac MRI analysis and EchoConfidence for echocardiography. Their human-in-the-loop AI technology delivers precision analysis across more than 100 cardiac measures, enhancing speed, accuracy, and diagnostic confidence for clinicians. MyCardium AI specializes in multiple cardiovascular conditions including amyloidosis (ATTR-CM), Fabry's disease, cardiomyopathies (HCM, DCM, ARVC), inflammatory cardiomyopathies, heart failure (HFrEF, HFpEF), myocarditis, aortic stenosis, cardio-oncology, and cell/gene therapies. In addition to their AI software products, the company operates CoreLab services that provide expert imaging analysis by doctors utilizing better-than-human AI software with industry-leading data management to support global clinical trials. Their CoreLab services cover site qualification, imaging documents, quality checks, and analysis for cardiac MRI and echocardiography studies. The company is led by world-leading cardiac imaging experts including Professor James Moon (CEO), Professor Charlotte Manisty (Director and Founder), and Professor Mark Westwood (Director and Founder), with Dr. Rhodri Davies serving as AI Development Lead. MyCardium AI maintains partnerships with major healthcare organizations including Optum and Change Healthcare Enterprise Imaging Healthcare.
Clinical Focus
Medical conditions and clinical areas addressed by Mycardium AI.
Who It Serves
Milestones & Awards
Recent Milestones
FDA 510(k) clearance and CE Class IIB certification for both 1CMR Pro and EchoConfidence products. NICE Draft Guidance 2026 recognition. CMR London conference reinstatement. Early career award SCMR 2024 London for precision diagnosis research.
Awards & Recognition
Early career award SCMR 2024 London for precision diagnosis of hypertrophic cardiomyopathy research
Key Partnerships
Company Details
- Headquarters
- Liverpool, Merseyside, England
Work here?
Claim this listing to update company information and connect with our audience.
Claim This ListingSecurity & Compliance
Official Sources
Similar Companies in this Market
View all 64 →
AccurKardia
AI-powered platform for cardiovascular disease detection and cardiac risk assessment.
Acorai
AI platform for cardiovascular disease detection and cardiac risk assessment.
Aisap
11-50 employees
AISAP provides FDA-cleared AI-powered diagnostic algorithms embedded in an operating system for point-of-care ultrasound (POCUS) devices. The platform enables rapid, expert-level cardiac imaging interpretation at the bedside, helping physicians detect structural heart disease early and make faster clinical decisions across hospitals, clinics, and screening programs.
AliveCor
AliveCor develops FDA-cleared, AI-powered ECG devices and software platforms for cardiac monitoring. The company offers portable ECG solutions ranging from consumer personal devices to clinical-grade 12-lead systems, serving patients, healthcare providers, biopharma companies, and health systems with remote and connected cardiac care.
Anumana AI
series c · 175 employees
Anumana AI develops and delivers AI-driven ECG algorithms to enable early diagnosis and intervention for cardiovascular conditions.
Artrya
11-50 employees
Artrya develops AI-powered solutions for rapid assessment of chest pain patients in emergency and primary care settings. The company's technology analyzes coronary computed tomography angiography (CCTA) to detect arterial plaque and stratify patient risk within minutes.
Bay Labs
Bay Labs is a health AI company focused on cardiology and cardiovascular health. The company's website is currently under construction with limited public information available.
BunkerHill Health
Bunkerhill Health provides Carebricks, an AI-powered platform that enables health systems to design, deploy, and operationalize AI agents across clinical and operational workflows. The platform reasons across patient data and automates actions within existing EHR systems.
Data Accuracy Notice: Company information on HealthAI Central is compiled from public sources and updated regularly. While we strive for accuracy, details such as funding figures, employee counts, and product offerings may change. We recommend verifying critical information directly with the company before making business decisions.